Macroeconomic challenges have exacted a toll on healthcare buyouts, but green shoots in deal activity reflect the industry’s strong fundamentals.

A once-in-a-generation technology surges into a centuries-old industry.

Despite the slowdown in dealmaking in 2023, healthcare IT retains its appeal to private equity investors.